Criminal
Jun. 5, 2010
Exec Admits to Manipulating Test
A former executive of a San Diego-based biotechnology firm admitted to manipulating the data for a new prenatal Down syndrome test then lying to investors about the test's accuracy.
Daily Journal Staff Writer
SAN DIEGO - A former executive of a biotechnology firm has admitted to manipulating the data for a new prenatal Down syndrome test and then lying to investors about the test's accuracy.
Elizabeth A. Dragon, 61, former senior vice president of research and development at Sequenom Inc. pleaded guilty to a criminal charge of conspiracy to commit securities fraud on Wednesday before U...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In